STATE OF NEW YORK ________________________________________________________________________ 6542 2023-2024 Regular Sessions IN SENATE April 26, 2023 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to newborn screening for glucose-6-phosphate dehydrogenase deficiency The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (j) of subdivision 1 of section 2500-a of the 2 public health law, as amended by chapter 70 of the laws of 2022, is 3 amended to read as follows: 4 (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative 5 enzymatic test or other diagnostic test in cases where: the newborn 6 infant presents with hemolytic anemia, hemolytic jaundice, or early-on- 7 set increasing neonatal jaundice, that is, jaundice (bilirubin level 8 greater than fortieth percentile for age in hours) persisting beyond the 9 day of birth through the week after birth; the newborn infant has been 10 admitted to the hospital for jaundice following birth; or the biological 11 parent of the newborn infant indicates a family, racial, or ethnic risk 12 of glucose-6-phosphate dehydrogenase deficiency, including having 13 significant African, Asian, Mediterranean, or Middle Eastern ancestry]. 14 § 2. This act shall take effect immediately. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD10869-02-3